PRESS / NEWS

STAY UP TO DATE WITH OUR NEWS.

PRESS CLIPPING

Novel Approaches to Overcome CRISPR In Vitro Delivery Challenges

This article is taken from European Biopharmaceutical Review October 2020, pages 34-37. © Samedan Ltd
Check the full content of the current issue.

In order for CRISPR gene editing to reach its full potential, we must develop in vitro delivery approaches that will allow us to work with hard-to-transfect cells, large repair templates, multiplex editing projects, and minimise off-target effects.

English  















European Biopharmaceutical Review | October 2020

PRESS RELEASE

CYTOSURGE ANNOUNCES APPOINTMENT OF THOMAS BACHMANN TO BOARD OF DIRECTORS

ZURICH | August 26, 2020

With his international management experience and extensive network in various life science markets, Thomas Bachmann is a great asset to Cytosurge and will continue to develop its strategic future markets.

English  Deutsch

PRESS RELEASE

OLYMPUS AND CYTOSURGE COLLABORATE TO DELIVER A COMPLETE SINGLE-CELL AND CRISPR GENETIC MANIPULATION SOLUTION IN THE AMERICAS

WALTHAM, MASS. & ZURICH | July 23, 2020

The FluidFM® BOT BIO Series combines Olympus’ renowned optics with Cytosurge’s cell manipulation expertise.

English  Deutsch

PRESS RELEASE

HARVARD’S WYSS INSTITUTE JOINS FORCES WITH CYTOSURGE TO IMPROVE CRISPR-BASED MULTIPLEXED GENE EDITING

BOSTON & ZURICH | May 4, 2020

Collaboration focuses on developing multiplexed gene editing approaches using single-cell nano-manipulation technology that maintains cell viability and fitness.

English  Deutsch

Harvard’s Wyss Institute collaborates with Cytosurge to enable multiplexed genome editing. Credit: Wyss Institute at Harvard University.

PRESS RELEASE

CYTOSURGE AG ANNOUNCES SPIN-OFF OF ITS 3D PRINTING BUSINESS UNIT

ZURICH | August 21, 2019

We are pleased to announce as of today that all 3D Printing activities of Cytosurge will be transitioned into an autonomous entity.

English  

PRESS RELEASE

PARTNERSHIP BETWEEN OLYMPUS EUROPE & CYTOSURGE

ZURICH & HAMBURG | July 9, 2019

Olympus Europe and Cytosurge partner to enhance pharma drug development and single cell research.

English  Deutsch

PRESS RELEASE

A METAL VERSION OF MICHELANGELO'S DAVID MADE IN MICROSCALE BY ADDITIVE MANUFACTURING

ZURICH | March 21, 2019

Probably one of the most famous art sculptures in the world recreated in an entirely new perspective.

English  Deutsch

LOOK BACK

FluidFM USER CONFERENCE

ZURICH | February 7, 2019

We are proud to have recently co-organized with ETH Zurich the latest FluidFM User Conference that has considerably broadened the FluidFM community, enabled mutual exchange of knowledge and experience, which will hopefully contribute to accelerating further research.

English  

PRESS RELEASE

IMPOSSIBLE OBJECTS MADE POSSIBLE

ZURICH | December 19, 2018

Can an "impossible object" be 3D printed, even impossibly small?

English  

PRESS RELEASE

PREMIUM PARTNERSHIP BETWEEN
BRUKER & CYTOSURGE

ZURICH | June 29, 2018

Enabling FluidFM® single cell experiments on the BioScope Resolve® BioAFM.

English  

PRESS RELEASE

FluidFM µ3Dprinter – A NEW FUNCTION ALLOWS UNIQUE PINPOINT METAL ADDITIVE MANUFACTURING

ZURICH | June 6, 2018

The FluidFM µ3Dprinter has received a major design upgrade and has been further improved with a new and unique function: Printing on existing structures with pinpoint (micrometer) accuracy.

English  

NEWS

NOVEL & UNIQUE:
FluidFM BOT FOR INJECTION

ZURICH | April 10, 2018

Conventional microinjection has its limits: these include limited cell viability, time-consuming experiments and difficulties in injecting into “small” adherent cells. The FluidFM BOT for Injection overcomes these limits.

English  

PRESS CLIPPING

SUCCESS STORIES:
SEARCHING FOR A FluidFM BOT DISTRIBUTION PARTNER IN GERMANY

ZURICH | April 5, 2018

Switzerland Global Enterprise, Silvana Giger

English  Deutsch

PRESS CLIPPING

GROWING INTEREST IN CYTOSURGE'S FluidFM TECHNOLOGY

ZURICH | February 2, 2018

startupticker.ch

English  

PRESS RELEASE

PARTNERSHIP BETWEEN
JPK INSTRUMENTS & CYTOSURGE

ZURICH | December 7, 2017

Making FluidFM available on the JPK Nanowizard® AFM platform.

English  

PRESS CLIPPING

NEW REVOLUTIONARY TOOLS FOR PHARMA AND MEDICAL RESEARCHERS READY TO GO FURTHER

November 17, 2017

GHP Magazine, November edition.

English  

PRESS RELEASE

PREMIUM PARTNERSHIP BETWEEN NANOSURF & CYTOSURGE

ZURICH | October 18, 2017

Taking FluidFM solutions to the next level.

English  

PRESS RELEASE

FluidFM SINGLE CELL EXTRACTION

ZURICH | July 14, 2016

Pioneering new method for the extraction of single living cells could revolutionise single cell analysis.

English  

PRESS RELEASE

FluidFM MICRO 3D PRINTING

ZURICH | January 20, 2016

Groundbreaking 3D micro-printing process opens new dimensions for the fabrication of microscopic metal structures.

English  Deutsch 

rendering_breit_1920-min.jpg

2x_bg_image_11.jpg

COMPANY PROFILE

The company’s vision is to provide a new generation of tools to stimulate novel applications at the forefront of nanotechnology, life sciences and single cell biology in particular. We are a passionate team of specialists with backgrounds in various disciplines from business, engineering, biology and computer science.

Company Brochure 

Zurich, Switzerland

Founded 2009

ETH Zurich Spin-off

Worldwide Distribution

Award winning